Human immunodeficiency virus (HIV)/hepatitis C virus (HCV) coinfection leads to severe systemic inflammation, increasing non-AIDS morbidity and mortality risk. CD39 ectoenzyme on T-cells, which ...

Psychological resilience is often misunderstood as simple "toughness" or an insensitivity to stress. However, true resilience is the brain's capacity to adapt and recover after a stressful event.

Leading scientists, policymakers, industry representatives and early-career researchers from across Europe will gather on 10-11 June 2026 at Wageningen University & Research (Netherlands) for the ...

Personality tests are widely used in workplaces to shape recruitment, leadership training and team building. But what if artificial intelligence could make them faster, smarter and more accurate? New ...

Play is critical for kids’ development — but ‘play’ in research is often defined by adult scientists, not the children themselves.

A study assesses whether perceiving a partner's effort leads to greater engagement of executive control mechanisms to maintain focus on a task.

Terahertz (THz) radiation is increasingly explored for biomedical applications, however, its non-thermal effects on cellular metabolism and regulatory networks remain insufficiently characterized.

The first randomized trial to test whether adding a small, temporary pump to allow the heart to rest and intentionally delaying percutaneous coronary intervention (PCI), also known as coronary ...

For patients with non-valvular atrial fibrillation (AFib) who had no contraindications to taking oral anticoagulants, the use of a device to close off the left atrial appendage in the heart—a small ...

Patients who had low doses of clot-buster drugs delivered directly to the site of a pulmonary embolism (PE) via a catheter using ultrasound to enhance their effect had significantly better outcomes ...

Using a microaxial flow pump prior to and during cardiac stenting procedures for patients with severe heart attacks who don't have cardiogenic shock does not significantly reduce heart damage.

Mass General Brigham researchers found that the intensive cholesterol‑lowering therapy evolocumab reduced the risk of a first major cardiovascular event in high‑risk patients who did not have known ...